HgeTx1

From WikiMD's WELLNESSPEDIA

HgeTx1 is a toxin isolated from the venom of the spider species Haplopelma gertschi. It is a potent inhibitor of the voltage-gated potassium channels Kv4.2 and Kv4.3, which are important for the regulation of neuronal excitability and cardiac function.

Structure and Function[edit]

HgeTx1 is a small protein composed of 33 amino acids. It belongs to the family of inhibitor cystine knot (ICK) toxins, which are characterized by their compact, stable structure formed by three disulfide bonds. The specific arrangement of these bonds in HgeTx1 is thought to be responsible for its high affinity for Kv4.2 and Kv4.3 channels.

The toxin acts by binding to the voltage-sensing domain (VSD) of the channels, thereby preventing their opening and inhibiting the flow of potassium ions. This results in an increase in neuronal excitability and can lead to arrhythmia in the heart.

Therapeutic Potential[edit]

Due to its specific action on Kv4.2 and Kv4.3 channels, HgeTx1 has potential for the development of new therapeutic agents. It could be used to modulate neuronal excitability in conditions such as epilepsy and neuropathic pain, or to regulate cardiac function in diseases like arrhythmia and heart failure.

However, further research is needed to fully understand the toxin's mechanism of action and to develop safe and effective methods for its delivery and use in a clinical setting.

See Also[edit]


This toxin-related article is a stub. You can help WikiMD by expanding it.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.